Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2026-02-11 @ 12:42 PM
Study NCT ID:
NCT00741195
Status:
COMPLETED
Last Update Posted:
2016-10-04
First Post:
2008-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer
Sponsor:
Hellenic Oncology Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CT/08.09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None